| Q39739858 | A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients with Chronic Low Back Pain |
| Q46365444 | A randomized, double-blind, placebo-controlled trial of duloxetine for the treatment of pain in patients with multiple sclerosis |
| Q38020236 | A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain |
| Q38073084 | A review of pharmacotherapy for chronic low back pain with considerations for sports medicine |
| Q38645616 | Adverse Effects of Antidepressants for Chronic Pain: A Systematic Review and Meta-analysis |
| Q43075748 | Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials |
| Q39196337 | Amitriptyline for musculoskeletal complaints: a systematic review |
| Q38181577 | Antidepressants in the treatment for chronic low back pain: questioning the validity of meta-analyses |
| Q96304206 | Are Opioids Needed to Treat Chronic Low Back Pain? A Review of Treatment Options and Analgesics in Development |
| Q90379841 | Are there really only 2 kinds of people in the world? Evaluating the distribution of change from baseline in pain clinical trials |
| Q33768713 | Assessment of direct analgesic effect of duloxetine for chronic low back pain: post hoc path analysis of double-blind, placebo-controlled studies |
| Q88651735 | Chronic low back pain: a mini-review on pharmacological management and pathophysiological insights from clinical and pre-clinical data |
| Q38118585 | Chronic low back pain: pharmacological, interventional and surgical strategies |
| Q37332002 | Clinical experience with duloxetine in the management of chronic musculoskeletal pain. A focus on osteoarthritis of the knee |
| Q34434307 | Combining opioid and adrenergic mechanisms for chronic pain |
| Q38645778 | Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials |
| Q24201220 | Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia |
| Q36071024 | Duloxetine in the management of chronic musculoskeletal pain |
| Q42875438 | Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis |
| Q47637575 | Duloxetine use in chronic low back pain: treatment patterns and costs |
| Q34754874 | Duloxetine use in chronic painful conditions--individual patient data responder analysis |
| Q35884946 | Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials |
| Q38547512 | Efficacy and Safety of Duloxetine on Osteoarthritis Knee Pain: A Meta-Analysis of Randomized Controlled Trials |
| Q36141335 | Efficacy of Duloxetine in Patients with Chronic Pain Conditions |
| Q34345461 | Efficacy of duloxetine versus alternative oral therapies: an indirect comparison of randomised clinical trials in chronic low back pain |
| Q35541036 | Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study |
| Q43093983 | Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain |
| Q48315767 | Evidence-based medicine in the management of chronic pain using noninvasive brain stimulation |
| Q38292223 | Expert opinion on emerging drugs: chronic low back pain |
| Q51509688 | General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. |
| Q42678028 | Long-term safety of duloxetine during open-label compassionate use treatment of patients who completed previous duloxetine clinical trials |
| Q64098890 | Maintenance of effect of duloxetine in Chinese patients with pain due to osteoarthritis: 13-week open-label extension data |
| Q104485818 | Management of non-specific low back pain in primary care - A systematic overview of recommendations from international evidence-based guidelines |
| Q37810291 | Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components |
| Q43096660 | Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies |
| Q37420136 | Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain |
| Q37350354 | Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care |
| Q92240399 | Relationship Between Pain Alleviation and Disease-specific Health-related Quality of Life Measures in Patients With Chronic Low Back Pain Receiving Duloxetine: Exploratory Post Hoc Analysis of a Japanese Phase 3 Randomized Study |
| Q41503574 | Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study |
| Q26744416 | Reward deficiency and anti-reward in pain chronification |
| Q34670741 | Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials |
| Q26775928 | The effect of journal impact factor, reporting conflicts, and reporting funding sources, on standardized effect sizes in back pain trials: a systematic review and meta-regression |
| Q37360532 | The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports. |
| Q48710783 | Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release |
| Q36235077 | Use of select medications prior to duloxetine initiation among commercially-insured patients |
| Q37840271 | Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies |
| Q33936266 | Work-related outcomes in randomised placebo-controlled pain trials: a systematic review and meta-analysis |